{"id":7427,"date":"2021-10-08T14:29:42","date_gmt":"2021-10-08T18:29:42","guid":{"rendered":"https:\/\/www.millerthomson.com\/deals-cases\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/"},"modified":"2026-01-20T18:51:39","modified_gmt":"2026-01-20T23:51:39","slug":"mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis","status":"publish","type":"deals-cases","link":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/","title":{"rendered":"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis"},"content":{"rendered":"<p>Le 1<sup>er<\/sup>\u00a0octobre\u00a02021, Mydecine Innovations Group (NEO:MYCO; OTC:MYCOF; FSE:0NFA) (\u00ab\u00a0Mydecine\u00a0\u00bb) annon\u00e7ait avoir conclu la transaction de scission (la \u00ab\u00a0transaction\u00a0\u00bb) de ALT House Cannabis Inc. (\u00ab\u00a0SpinCo\u00a0\u00bb), une filiale en propri\u00e9t\u00e9 exclusive de Mydecine qui d\u00e9tenait ses actifs am\u00e9ricains li\u00e9s au cannabis.<\/p>\n<p>La personne morale SpinCo a \u00e9t\u00e9 constitu\u00e9e le 9\u00a0ao\u00fbt\u00a02021 aux fins de la transaction, permettant ainsi \u00e0 Mydecine de transf\u00e9rer \u00e0 SpinCo la totalit\u00e9 de ses int\u00e9r\u00eats dans\u00a0: (i) 1176392 BC Ltd; (ii) Alternative Distribution Company, LLC; (iii) Drink Fresh Water, LLC; (iv) Tealief Brands, LLC; (v) Relyfe Brands, LLC; (vi) We are Kured, LLC; et (vii) Trellis Holdings Oregon OP, LLC (collectivement, les \u00ab\u00a0filiales am\u00e9ricaines li\u00e9es au cannabis\u00a0\u00bb) en \u00e9change de 2?500?000\u00a0actions ordinaires de SpinCo (les \u00ab\u00a0actions SpinCo\u00a0\u00bb). Les actionnaires actuels de Mydecine ont re\u00e7u pour chaque action ordinaire de Mydecine d\u00e9tenue\u00a0: a) une nouvelle action ordinaire de Mydecine, et b) 0,010300\u00a0action de SpinCo. Les nouvelles actions ordinaires de Mydecine devraient continuer \u00e0 \u00eatre n\u00e9goci\u00e9es \u00e0 la bourse NEO Exchange le 1<sup>er<\/sup>\u00a0octobre\u00a02021. Les d\u00e9tenteurs de bons de souscription de Mydecine (NEO: MYCO.WT) qui exercent valablement ces bons \u00e0 la suite de la transaction recevront, pour chaque bon d\u00e9tenu, une action ordinaire enti\u00e8re de Mydecine et, sans devoir verser de contrepartie suppl\u00e9mentaire, 0,010300\u00a0action SpinCo. Les num\u00e9ros CUSIP des nouvelles actions Mydecine et des actions SpinCo seront respectivement 62849F101 et 021242102.<\/p>\n<p>Mydecine est une soci\u00e9t\u00e9 biopharmaceutique de stade clinique qui cherche \u00e0 transformer le traitement des maladies mentales et des d\u00e9pendances.<\/p>\n<p>L\u2019\u00e9quipe de Miller Thomson qui a conseill\u00e9 Mydecine dans le cadre de cette transaction \u00e9tait dirig\u00e9e par Lawrence Wilder (march\u00e9s financiers et valeurs mobili\u00e8res) et compos\u00e9e de Mack Hosseinian et Mark Milanetti (march\u00e9s financiers et valeurs mobili\u00e8res).<\/p>\n","protected":false},"author":1,"template":"","class_list":["post-7427","deals-cases","type-deals-cases","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis | Miller Thomson<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis | Miller Thomson\" \/>\n<meta property=\"og:description\" content=\"Conseillers juridiques de Mydecine Innovations Group\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/\" \/>\n<meta property=\"og:site_name\" content=\"Miller Thomson\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-20T23:51:39+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@millerthomson\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/\",\"name\":\"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis | Miller Thomson\",\"isPartOf\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\"},\"datePublished\":\"2021-10-08T18:29:42+00:00\",\"dateModified\":\"2026-01-20T23:51:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions et mandats\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"description\":\"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.\",\"publisher\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"contentUrl\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"width\":380,\"height\":50,\"caption\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\"},\"image\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\",\"https:\/\/x.com\/millerthomson\",\"https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/\",\"https:\/\/www.youtube.com\/@millerthomson\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis | Miller Thomson","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/","og_locale":"fr_FR","og_type":"article","og_title":"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis | Miller Thomson","og_description":"Conseillers juridiques de Mydecine Innovations Group","og_url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/","og_site_name":"Miller Thomson","article_publisher":"https:\/\/www.facebook.com\/MillerThomsonLaw\/","article_modified_time":"2026-01-20T23:51:39+00:00","twitter_card":"summary_large_image","twitter_site":"@millerthomson","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/","url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/","name":"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis | Miller Thomson","isPartOf":{"@id":"https:\/\/www.millerthomson.com\/fr\/#website"},"datePublished":"2021-10-08T18:29:42+00:00","dateModified":"2026-01-20T23:51:39+00:00","breadcrumb":{"@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-conclut-la-scission-de-ses-actifs-americains-lies-au-cannabis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.millerthomson.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Transactions et mandats","item":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/"},{"@type":"ListItem","position":3,"name":"Mydecine conclut la scission de ses actifs am\u00e9ricains li\u00e9s au cannabis"}]},{"@type":"WebSite","@id":"https:\/\/www.millerthomson.com\/fr\/#website","url":"https:\/\/www.millerthomson.com\/fr\/","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","description":"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.","publisher":{"@id":"https:\/\/www.millerthomson.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.millerthomson.com\/fr\/#organization","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","url":"https:\/\/www.millerthomson.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","contentUrl":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","width":380,"height":50,"caption":"Miller Thomson | Cabinet de droit des affaires pancanadien"},"image":{"@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MillerThomsonLaw\/","https:\/\/x.com\/millerthomson","https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/","https:\/\/www.youtube.com\/@millerthomson"]}]}},"_links":{"self":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7427","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases"}],"about":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/types\/deals-cases"}],"author":[{"embeddable":true,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7427\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/media?parent=7427"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}